Venture Capital Funds
While growing our investment portfolio, The Case for Her realized that we had an opportunity to address the structural issues and lack of funding for companies that directly address the key health issues that we are so passionate about.
By moving upstream in the funding “supply chain” by investing in women-led venture capital funds, we can support brilliant female venture capitalists who support women-led and women-founded businesses while simultaneously increasing the number of goods and services designed by and with women in mind, and which address women’s needs.
As women-led startups and startups directed at women emerge, we need people around the table that understand and support them. By adding female perspectives to due-diligence models and other points of traditional validation, we can redesign the financial ecosystem to not only include women founders but to actively encourage them and the markets that they serve.
Our investments in these venture capital funds have helped fund 34 other women's health companies.
Amboy Street Ventures is world’s first venture capital fund focused on Sexual Health & Women’s Health Technology startups. Amboy Street Ventures is an active investor and adds value above and beyond capital. Its dedicated Value Enhancement Team supports portfolio companies with marketing & branding, sales & distribution, product development & scientific innovation and public education resources through its position within the Healthy Pleasure Group, an ecosystem dedicated to solving the problems that startups face in the Sexual Health and Women’s Health Tech market.
Coyote Ventures backs founders who are solving problems that disproportionately affect overlooked populations, with a foundation in women’s health. Founded by scientists, entrepreneurs, and investors, Coyote takes an integrative view of health that spans physical, financial, and emotional health. The Coyote team includes 11 Venture Partners and over 50 expert advisors. Coyote has completed 10 investments, and is actively investing to create a synergistic portfolio of innovative health-centric solutions.
RH Capital, a Rhia Ventures fund, is an impact-first venture capital fund that invests in early stage startups promising to revolutionize women’s health and improve health equity in the US.
Unconventional Ventures invests in startups in the pre-seed and seed range led by diverse founders identifying as women, people of color, immigrants and/or LGBTQ+, building scalable impact tech companies in the Nordics and beyond.
“The Case for Her is truly pioneering what it means to have real impact on women’s health. Their diverse portfolio of startups, VCs, films, and non-profits show their deep understanding of the women’s health ecosystem. They have been critical supporters of Coyote Ventures, joining our first close and really believing in what we’re building since the beginning, and making introductions to additional values aligned investors. We’re forever grateful for The Case for Her and excited for all that we’re building together!”
Jessica Karr, General Partner